S. Mandel, et al. Iron dysregulation in Alzheimer’s disease: Mul- timodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-proces- sing regulatory activities as therapeutic agents. Progress in Neurobiology, 2007, 82(6): 348-360.